Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19 - Université Paris-Est-Créteil-Val-de-Marne Accéder directement au contenu
Article Dans Une Revue PLoS Pathogens Année : 2021

Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19

Christophe Rodriguez
Nicolas de Prost
Slim Fourati
  • Fonction : Auteur
Claudie Lamoureux
Guillaume Gricourt
Melissa N’debi
  • Fonction : Auteur
Florence Canoui-Poitrine
Isaac Désveaux
Oriane Picard
Vanessa Demontant
  • Fonction : Auteur
Elisabeth Trawinski
  • Fonction : Auteur
Raphaël Lepeule
  • Fonction : Auteur
Laure Surgers
  • Fonction : Auteur
William Vindrios
  • Fonction : Auteur
Jean-Daniel Lelièvre
Nicolas Mongardon
Olivier Langeron
José Cohen
Armand Mekontso-Dessap
Jean-Michel Pawlotsky

Résumé

COVID-19 is characterized by respiratory symptoms of various severities, ranging from mild upper respiratory signs to acute respiratory failure/acute respiratory distress syndrome associated with a high mortality rate. However, the pathophysiology of the disease is largely unknown. Shotgun metagenomics from nasopharyngeal swabs were used to characterize the genomic, metagenomic and transcriptomic features of patients from the first pandemic wave with various forms of COVID-19, including outpatients, patients hospitalized not requiring intensive care, and patients in the intensive care unit, to identify viral and/or host factors associated with the most severe forms of the disease. Neither the genetic characteristics of SARS-CoV-2, nor the detection of bacteria, viruses, fungi or parasites were associated with the severity of pulmonary disease. Severe pneumonia was associated with overexpression of cytokine transcripts activating the CXCR2 pathway, whereas patients with benign disease presented with a T helper “Th1-Th17” profile. The latter profile was associated with female gender and a lower mortality rate. Our findings indicate that the most severe cases of COVID-19 are characterized by the presence of overactive immune cells resulting in neutrophil pulmonary infiltration which, in turn, could enhance the inflammatory response and prolong tissue damage. These findings make CXCR2 antagonists, in particular IL-8 antagonists, promising candidates for the treatment of patients with severe COVID-19.

Dates et versions

hal-04298446 , version 1 (21-11-2023)

Identifiants

Citer

Christophe Rodriguez, Nicolas de Prost, Slim Fourati, Claudie Lamoureux, Guillaume Gricourt, et al.. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19. PLoS Pathogens, 2021, 17 (3), pp.e1009416. ⟨10.1371/journal.ppat.1009416⟩. ⟨hal-04298446⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More